- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e76e822c-fad7-49e0-970c-47926843db34 - Date
1/12/2016 - Company Name
Ancera - Mailing Address
21 Business Park Drive Branford, CT 06405 USA - Company Description
The company is developing a rapid, portable technology platform for the separation, quantitative detection and identification of minute concentrations of various pathogens from whole blood or other bodily fluids. Ancera’s platform is based on technology it is licensing exclusively from Yale University. - Website
http://www.anceradx.com - Transaction Type
Venture Equity - Transaction Amount
$1,093,998 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed